Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 28, 2022

SELL
$114.02 - $139.04 $9,121 - $11,123
-80 Closed
0 $0
Q4 2021

Feb 02, 2022

BUY
$115.53 - $141.46 $9,242 - $11,316
80 New
80 $11,000
Q4 2019

Jan 22, 2020

SELL
$78.51 - $87.4 $39,255 - $43,700
-500 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$81.84 - $88.74 $40,920 - $44,370
500 New
500 $42,000
Q2 2019

Jul 30, 2019

SELL
$72.88 - $85.0 $7,288 - $8,500
-100 Closed
0 $0
Q1 2019

Apr 26, 2019

BUY
$66.22 - $80.06 $2,450 - $2,962
37 Added 58.73%
100 $8,000
Q4 2018

Feb 15, 2019

SELL
$65.56 - $74.27 $33,435 - $37,877
-510 Reduced 89.01%
63 $5,000
Q3 2018

Nov 02, 2018

BUY
$60.81 - $73.36 $31,013 - $37,413
510 Added 809.52%
573 $42,000
Q2 2018

Aug 03, 2018

BUY
$57.57 - $63.54 $3,626 - $4,003
63 New
63 $4,000
Q4 2017

Feb 02, 2018

SELL
$53.68 - $57.47 $33,550 - $35,918
-625 Closed
0 $0
Q3 2017

Nov 20, 2017

BUY
$48.06 - $53.64 $30,037 - $33,525
625
625 $33,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Barnett & Company, Inc. Portfolio

Follow Barnett & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barnett & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Barnett & Company, Inc. with notifications on news.